BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29700008)

  • 1. Smoking and Prostate Cancer-Specific Mortality after Diagnosis in a Large Prospective Cohort.
    Gansler T; Shah R; Wang Y; Stevens VL; Yang B; Newton CC; Gapstur SM; Jacobs EJ
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):665-672. PubMed ID: 29700008
    [No Abstract]   [Full Text] [Related]  

  • 2. Recreational Physical Activity in Relation to Prostate Cancer-specific Mortality Among Men with Nonmetastatic Prostate Cancer.
    Wang Y; Jacobs EJ; Gapstur SM; Maliniak ML; Gansler T; McCullough ML; Stevens VL; Patel AV
    Eur Urol; 2017 Dec; 72(6):931-939. PubMed ID: 28711382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer.
    Jacobs EJ; Newton CC; Stevens VL; Campbell PT; Freedland SJ; Gapstur SM
    J Clin Oncol; 2014 Nov; 32(33):3716-22. PubMed ID: 25332245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lycopene, tomato products and prostate cancer-specific mortality among men diagnosed with nonmetastatic prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
    Wang Y; Jacobs EJ; Newton CC; McCullough ML
    Int J Cancer; 2016 Jun; 138(12):2846-55. PubMed ID: 26830232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM).
    Russo AL; Chen MH; Aizer AA; Hattangadi JA; D'Amico AV
    BJU Int; 2012 Oct; 110(7):973-9. PubMed ID: 22954029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postdiagnosis Body Mass Index, Weight Change, and Mortality From Prostate Cancer, Cardiovascular Disease, and All Causes Among Survivors of Nonmetastatic Prostate Cancer.
    Troeschel AN; Hartman TJ; Jacobs EJ; Stevens VL; Gansler T; Flanders WD; McCullough LE; Wang Y
    J Clin Oncol; 2020 Jun; 38(18):2018-2027. PubMed ID: 32250715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.
    Gnanapragasam VJ; Lophatananon A; Wright KA; Muir KR; Gavin A; Greenberg DC
    PLoS Med; 2016 Aug; 13(8):e1002063. PubMed ID: 27483464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snus use, smoking and survival among prostate cancer patients.
    Wilson KM; Markt SC; Fang F; Nordenvall C; Rider JR; Ye W; Adami HO; Stattin P; Nyrén O; Mucci LA
    Int J Cancer; 2016 Dec; 139(12):2753-2759. PubMed ID: 27582277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men.
    Gong Z; Agalliu I; Lin DW; Stanford JL; Kristal AR
    Cancer Causes Control; 2008 Feb; 19(1):25-31. PubMed ID: 17906959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco smoking and death from prostate cancer in US veterans.
    Riviere P; Kumar A; Luterstein E; Vitzthum LK; Nalawade V; Sarkar RR; Bryant AK; Einck JP; Mundt AJ; Murphy JD; Rose BS
    Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):252-259. PubMed ID: 31624316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active smoking and mortality among colorectal cancer survivors: the Cancer Prevention Study II nutrition cohort.
    Yang B; Jacobs EJ; Gapstur SM; Stevens V; Campbell PT
    J Clin Oncol; 2015 Mar; 33(8):885-93. PubMed ID: 25646196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer.
    Tsai HK; Chen MH; McLeod DG; Carroll PR; Richie JP; D'Amico AV
    Cancer; 2006 Dec; 107(11):2597-603. PubMed ID: 17039498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of smoking on prostate cancer survival: a cohort analysis in Barcelona.
    Murta-Nascimento C; Romero AI; Sala M; Lorente JA; Bellmunt J; Rodero NJ; Lloreta J; Hospital À; Burón A; Castells X; Macià F
    Eur J Cancer Prev; 2015 Jul; 24(4):335-9. PubMed ID: 25075878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
    Zhou P; Chen MH; McLeod D; Carroll PR; Moul JW; D'Amico AV
    J Clin Oncol; 2005 Oct; 23(28):6992-8. PubMed ID: 16192586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mortality after androgen-deprivation therapy in patients with rapidly rising prostate-specific antigen levels after local therapy for prostate cancer.
    Rodrigues NA; Chen MH; Catalona WJ; Roehl KA; Richie JP; D'Amico AV
    Cancer; 2006 Aug; 107(3):514-20. PubMed ID: 16795068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.
    Aizer AA; Chen MH; Hattangadi J; D'Amico AV
    BJU Int; 2014 Jan; 113(1):43-50. PubMed ID: 23473327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on "initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer." Aizer AA, Chen MH, Hattangadi J, D'Amico AV. Harvard Radiation Oncology program, Boston, MA.: BJU Int 2013. doi: 10.1111/j.1464-410X.2012.11789.x. [Epub ahead of print].
    Ritter MA
    Urol Oncol; 2014 Feb; 32(2):208-9. PubMed ID: 24445289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer.
    Raldow AC; Zhang D; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
    JAMA Oncol; 2015 Jun; 1(3):334-40. PubMed ID: 26181182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.
    FitzGerald LM; Zhao S; Leonardson A; Geybels MS; Kolb S; Lin DW; Wright JL; Eeles R; Kote-Jarai Z; Govindasami K; Giles GG; Southey MC; Schleutker J; Tammela TL; Sipeky C; Penney KL; Stampfer MJ; Gronberg H; Wiklund F; Stattin P; Hugosson J; Karyadi DM; Ostrander EA; Feng Z; Stanford JL
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):228-237. PubMed ID: 29298992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.